• Explore /
  • Poster
  • / Prognostic factors of trastuzumab-based chemotherapy in patients with advanced HER2 positive gastric cancer.

Prognostic factors of trastuzumab-based chemotherapy in patients with advanced HER2 positive gastric cancer.

Abstract Poster

Authors

null

Shoko Marshall

Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

Shoko Marshall , Takeru Wakatsuki , Tomohiro Matsushima , Hiroki Osumi , Mariko Ogura , Takashi Ichimura , Daisuke Takahari , Eiji Shinozaki , Keisho Chin , Kensei Yamaguchi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Prevention, Diagnosis, and Screening

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 41)

DOI

10.1200/JCO.2017.35.4_suppl.41

Abstract #

41

Poster Bd #

E19

Abstract Disclosures

Similar Posters

First Author: Yelena Y. Janjigian

First Author: Daniel V.T. Catenacci

First Author: Yasuyuki Kawamoto

First Author: Daniel V.T. Catenacci